Ruth McDonald Acknowledgements SDO, Department of Health, Commonwealth Fund Sudeh Cheraghi-Sohi, Martin Tickle, Martin.

Slides:

Advertisements

Similar presentations

PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.

Advertisements

The Advanced Practice Nurse Managed Clinic: Nurses Responding to Change Rosemary Goodyear Ed.D, APRN-BC, FAANP.

Chris Town Chief Executive Greater Peterborough Primary Care Partnership Chair, New Contractual Framework for Community Pharmacy Negotiating Group The.

Methods of Financing Healthcare James Thompson Government Actuarys Department United Kingdom.

Local Commissioning Groups (LCG) The Health and Social Services Authority (Designate) together with the BMA (NI) held a series of evening roadshows for.

Understanding the NHS reforms Jo Webber, Deputy Policy Director 20 th March 2012.

Managing the Mental Health Merry Go Round Karalyn Huxhagen B Pharm FPS AACPA.

Health Systems and Actors Tom Merrick, World Bank.

MEDICAL HOME 1/2009 Mary Goldman, D.O., President of MAOFP.

Community Pharmacy – Call to Action Derbyshire / Nottinghamshire Area Team.

The vision for NHS Community Pharmacies The path to improved patient care.

Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.

Building the Digital Infrastructure for Vermont’s Learning Health System ONC HIT Policy Committee Testimony September 14, 2011 Hunt Blair, Deputy Commissioner.

Pharmaceutical Sciences NON MEDICAL PRESCRIBING Non Medical Prescribing Alison Hogg.

How knowledge services can support the new commissioners? Tim Jones NHS Commissioning specialist.

Unsupported and over stretched pharmacists: is there a role for the regulator? Karen Hassell Ellen Schafheutle The Centre for Pharmacy Workforce Studies.

Sustaining General Practice in Challenging Environments Remote and Rural Perspective By Dr Susan Taylor.

Gail Yapp Assistant Secretary Acute Care Reform The future of subacute care in view of the report of the National Health and Hospitals Reform Commission.

1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.

Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.

Clincal Nurse Leader in the Community Pamela N. Clarke Fay W. Whitney School of Nursing University of Wyoming.

Capacity Task Force Virginia Health Reform Initiative January 14, 2011

Achieving improved cancer outcomes- a pathway approach, engaging primary care and partners Kathy Elliott Programme Director – NHS Improving Quality (Delivery.

3 April 2008Bellagio Improving cooperation for better chronic care Chris Ham HSMC University of Birmingham.

Health Care Reform: Where are the Pharmacists? Opportunities and Challenges for Pharmacists in Health Care Reform Anthony D. Rodgers CMS Deputy Administrator.

WP5 Outpatient and Home care WP Leader Prof. John Hutton Dept. Health Sciences and York Health Economics Consortium.

1. How can we promote pharmacies and the full service available? Think about: How the NHS works with Local Authorities to enhance the role of community.

The Pharmaceutical Care of Patients with Long Term Conditions Deirdre Watt Team Leader, Community Pharmacy Scottish Government.

Health Strategy Management Contracting and Commissioning 5th February 2015 Pam Kaur Group Finance Manager University Hospitals Coventry & Warwickshire.

Financial incentives for quality in UK primary medical care Ruth McDonald Nottingham University Business School National Workshop on Results-Based Financing.

Read and delete this slide In the April 2013 edition of CPN and on the PSNC website, a short contractor briefing on the new healthcare system was published.contractor.

The Perfect Storm – are we eQIPP’d to survive it? Peter Rowe, National QIPP Lead – Medicines Use and Procurement Rowe Creative Limited ©

Summary from the Economics Track With thanks to all track participants, presenters, rapporteurs, moderators and organizers.

Organisational Journey Supporting self-management

UKMi Strategy 2007 Replaces 2000 Strategy Launched 31/10/2007 Takes account of political, policy, organisational and operational NHS changes Takes account.

© Nuffield Trust 24 October 2015 NHS payment reform: evolving policy and emerging evidence Chief Economist: Anita Charlesworth.

Primary Care FIT FOR 20:20 GP Contract – what next? Primary Care Division Scottish Government.

Training Primary Care Pharmacists Paula Wilkinson Chief Pharmacist Mid-Essex CCG.

The Australian Model for Home Medicines Review Dr Tim Chen Faculty of Pharmacy 9 th Commonwealth Pharmaceutical Association Conference.

The New NHS Opportunities for Optometrists Chris Town Acting Chief Executive Cambridgeshire PCT.

Pay for Performance, Public Reporting, and Disparities: What Do We Know? The Experience of UK Primary Care Tim Doran, University of Manchester Fullwood.

The Commissioning and Delivery System for children and young people’s mental health Lisa Williams, Consultant and member of the BOND Consortium.

Briefing on General Practice Julian Spinks. Areas to consider The state of general practice New configurations Practice Based Commissioning QOF changes.

Educational support for Shifting the Balance of Care (SBC) Strategic Environment  Better Health Better Care 2007  A Force for improvement – Workforce.

Nhs Managers.net Dr Clare Gerada RCGP. Without the right investment and infrastructure, general practice will not be able to be an effective provider.

Markets or professionalism: Lessons from two devolved health care systems in the UK. C O'Donnell et al.

GMS Update – PBC, NICE guidelines, new protocols Meeting Stephen Newell & Sue Neal.

Improving Purchasing of Clinical Services* 21 st October 2005 *connectedthinking 

Overview and Scrutiny Committee Herts 2007 The New Dental Contract 12 months on Sue Gregory Consultant in Dental Public Health.

NHS reforms and impact on Pharmacy. Objective Update on the NHS reforms and Public Health and Education Landscapes Outline new structures, organisations.

Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.

The Bologna Process and professional regulation in the UK Damian Day, Head of Accreditation, Royal Pharmaceutical Society of Great Britain.

Psnc.org.uk/campaign #lovemypharmacy Community Pharmacy in 2016/17 and beyond The Community Pharmacy Review 2016/17.

Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.

Managing Clinicians or Just Filling Shifts ? Dr Mark Reynolds CEO and Medical Director On Call Care Ltd.

‘Enhancing musculoskeletal research in primary care: engaging a community musculoskeletal physiotherapy service in research studies’ Presented by : Carol.

Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.

Pharmacy White Paper Building on Strengths Delivering the Future Overview.

All-Payer Model Update

Safer Staffing – Integrated Care Teams The Right Staff, with the Right Skills, in the Right Place at the Right Time Sara Courtney – Head of Professions.

Think Pharmacy Sue Sharpe CEO PSNC.

Integrating Clinical Pharmacy into a wider health economy

The new Professional Leadership Body: supporting advanced and specialist practice Dr Catherine Duggan.

in support of Primary Care Clusters :

in support of Primary Care Clusters :

Community Pharmacy: in support of Primary Care Clusters

All-Payer Model Update

Issues on Dispensing Dr Percy Mahlathi.

More Than One-Third of Women in the U. S. Skip Care Because of Cost vs

Community Pharmacy: your local healthcare team

Presentation transcript:

Ruth McDonald

Acknowledgements SDO, Department of Health, Commonwealth Fund Sudeh Cheraghi-Sohi, Martin Tickle, Martin Roland, Tim Doran, Stephen Campbell, Steve Harrison, Darren Ashcroft, Caroline Sanders, Russell Mannion, Keith Milsom.

Methods

What do we mean by professional?

‘New’ professionalism? Dynamic context Changes to incentive structures Aligning payment to policy goals GP contract & Practice-based Commissioning (PBC)2004 Pharmacy contract 2005 Dental contract 2006 Policy goals multiple, complex and competing

GP contract Self-employed contractors (partnerships) Quality and outcomes framework (QOF) Contract with practice End to OOH Software to facilitate delivery Negotiated, ballot, own data New money, MPIG

Impact? Self surveillance Surveillance by others (including non doctors) Hierarchy

Impact? Critical of other practices Improvements in other practices Acceptance of public accountability

PBC GPs act as commissioners Elites & rank & file New strata Surveillance of self & by others

Pharmacy Professional status Business vs. public interest Control over the substance of work ‘Incomplete professionals’ (Denzin & Mettlin 1968) Subordinate to medicine Increasingly ‘corporate’ Divisions/ fragmentation

Professional status Conflict with business concerns overstated Knowledge imbues drug with social significance Pharmacists respond to disorder, ‘providing tools for the sick person to respond to the question “What is happening to me? What do the disordered senses of my body mean?”’ (Dingwall and Wilson 1995: 122).

Pharmacy contract Contractors 61% multiples (>5 pharmacies) Essential (dispensing) Enhanced (smoking cessation, minor ailments) Advanced

MURs Consultation room £28 per MUR Max 400 per annum Copy to GP & patient

MUR volumes

Professional status Targets for MURs Tick box MURs Home delivery of medicines Delegation to other staff Competitive market

Dental contract End to open ended funding End to patient registration UDAs Band 1 - Diagnosis, treatment planning and maintenance 1 UDA Band 2 – Treatment (e.g. fillings, root canal treatment, extractions) 3 UDAs Band 3 - Complex treatment that includes a lab element (e.g. bridges, crowns) 12 UDAs

Our findings are consistent with economic theory that suggests that No of extractions vs. year No of root-fillings vs. year

Summary a contribution to high levels of attainment of quality targets and a reduction, over time, in the variation in care quality related to deprivation in general medical practice increasing volumes of incentivised activities in community pharmacy a shift towards dental treatments which pay more, relative to effort expended

Many thanks